ARCHIVES

FDA News: Zydelig approved in three B-cell blood cancers

This article is from The Cancer Letter archive.

Vol. 40 No. 31 | August 1, 2014

Download PDF Visit The Full Archive

Related Articles

Michael Friedman To Head PhRMA’s Office Of Biomedical Preparedness.

November 2, 2001

NCI’s International Program Growing, With More Agreements, $8 Million In Contracts And Grants

August 8, 1975

Bethesda System Revised For Reporting Pap Test Results

April 26, 2002

Leukemia Society Program In Transitional Research.

January 14, 2000

In Aftermath of NEJM Article, Critic Bailar Declares The Defeat Of Cancer Treatment

June 6, 1997

NCI Plans To Issue Frederick Operations Contract As Sole-Source To SAIC-Frederick Inc. For Up To 10 Years.

November 10, 2006